Health-care companies rose, as traders rotated into sectors better equipped for an inflationary era.
Shares of Novavax slid after Bank of America Securities warned the vaccine maker could be hurt by lackluster Covid 19 booster uptake and increasing competition in the respiratory syncytial virus (RSV) and flu markets.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
05-20-22 1706ET
